Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1679
interventional 1053
Observational 512
Registry 114

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Device 254
Drug 218
Procedure 204
Other 95
Drug|placebo 86
Behavioral 48
Device|Drug 23
Drug|Procedure 22
Device|Procedure 18
Device|Other 14
Diagnostic Test 14
Drug|Other 11
Behavioral|Other 7
Other|Procedure 7
Device|Drug|Procedure 5
Behavioral|Device 3
Diagnostic Test|Other 2
Dietary Supplement 2
Dietary Supplement|placebo 2
Drug|Other|Procedure 2
Drug|placebo|Procedure 2
Genetic 2
Behavioral|Drug 1
Behavioral|Genetic 1
Biological 1
Biological|Device 1
Biological|placebo 1
Combination Product 1
Device|Drug|Other 1
Device|Other|Procedure 1
Dietary Supplement|Drug|Other 1
Drug|Genetic 1
Drug|Other|placebo 1
placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 253
Canada 77
Germany 51
United Kingdom 47
NA 45
Korea, Republic of 40
France 35
China 34
Denmark 27
Italy 25
Netherlands 22
Japan 20
Spain 20
United States|Canada 18
Russian Federation 17
Norway 14
Sweden 14
Belgium 11
Brazil 8
Czechia 7
Finland 7
Switzerland 7
Israel 6
Poland 6
Taiwan 6
Austria 5
Australia 4
Czechia|France 4
Egypt 4
Greece 4
Hong Kong 4
Iran, Islamic Republic of 4
United States|Russian Federation 4
France|Germany 3
Australia|Canada 2
Belgium|Netherlands 2
Croatia|Czechia 2
Czech Republic 2
Czech Republic|Germany 2
Israel|Russian Federation 2
Lebanon 2
Malaysia 2
Netherlands|Spain 2
Turkey 2
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Czech Republic|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|Italy|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 2
United States|Belgium|Netherlands 2
United States|Canada|Korea, Republic of 2
United States|Germany 2
United States|Italy 2
United States|Netherlands 2
Argentina|Australia|Belgium|Croatia|France|Germany|Italy|Netherlands|Norway 1
Argentina|Brazil|China|India|Romania 1
Argentina|United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czechia|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Russian Federation|Singapore|Slovakia|Slovenia|Spain|Sweden|Taiwan|Thailand|Turkey|United Kingdom 1
Australia|Austria|Belgium|Canada|France|Germany 1
Australia|Austria|Belgium|Netherlands|Russian Federation|Slovakia|United Kingdom 1
Australia|Austria|Denmark|Germany|New Zealand|Spain|Switzerland 1
Australia|Austria|Estonia|Finland|France|Germany|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Portugal|Spain|Switzerland|Taiwan|United Kingdom 1
Australia|Austria|Germany|Hungary|Netherlands|Poland|Russian Federation|United Kingdom 1
Australia|Belgium|Bulgaria|Croatia|Czech Republic|Denmark|Estonia|Germany|Hungary|Lithuania|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Ukraine 1
Australia|Canada|China|Germany|Israel 1
Australia|Canada|Czech Republic|Denmark|Estonia|Finland|France|Germany|Latvia|Lithuania|Netherlands|Poland|Serbia|Slovakia|Sweden|Ukraine 1
Australia|France|Germany|Hong Kong|Italy 1
Australia|France|Germany|Italy|Portugal|United Kingdom 1
Australia|Germany|Malaysia|New Zealand|United Kingdom 1
Australia|Hong Kong|Singapore 1
Austria|Belgium|Canada|Czech Republic|Germany|Netherlands|Russian Federation|Slovakia 1
Austria|Belgium|Canada|Czechia|France|Hungary|Italy|Japan|Latvia|Netherlands|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|Czechia|Italy 1
Austria|Belgium|Denmark|France|Germany|Italy|Spain|Switzerland 1
Austria|Belgium|Denmark|France|Ireland|Italy|Netherlands|Switzerland|United Kingdom 1
Austria|Belgium|Finland|Germany|Greece|Ireland|Israel|Japan|Norway|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Hungary|Italy|Korea, Republic of|Lithuania|Netherlands|Poland|Portugal|Romania|Serbia|Spain|Switzerland|Taiwan|Ukraine|United Kingdom 1
Austria|Czechia|France|Germany|Italy|Portugal|Spain 1
Austria|Germany|Netherlands 1
Belgium|Bulgaria|Croatia|Czechia|Denmark|Estonia|Hungary|Latvia|Lithuania|Poland|Russian Federation|Serbia|Slovakia|Spain|Ukraine 1
Belgium|Canada|Czechia|Germany|Hungary|Italy|Korea, Republic of|Poland|Spain|Taiwan|United Kingdom 1
Belgium|Canada|Czechia|Germany|Netherlands|United Kingdom 1
Belgium|Canada|Czechia|United Kingdom 1
Belgium|Canada|Denmark|France|Italy|Spain|Sweden 1
Belgium|Canada|Germany|Italy|Netherlands 1
Belgium|Czech Republic|Denmark|Finland|France|Germany|Hungary|Italy|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Czech Republic|France|Italy|Netherlands|Poland|Spain|Sweden|Switzerland 1
Belgium|Czechia|Denmark|France|Germany|Italy 1
Belgium|Czechia|Denmark|France|Germany|Italy|Netherlands|Poland|Spain|Switzerland|United Kingdom 1
Belgium|Czechia|Denmark|Italy 1
Belgium|Czechia|Germany|Greece|Hungary|Israel|Spain 1
Belgium|Czechia|Germany|United Kingdom 1
Belgium|Czechia|Netherlands 1
Belgium|France|Germany|Hungary|Italy|Netherlands|Poland|Russian Federation|Spain 1
Belgium|France|Germany|Hungary|Netherlands|United Kingdom 1
Belgium|France|Germany|Italy|Spain|Switzerland|United Kingdom 1
Belgium|France|Germany|United Kingdom 1
Brazil|Canada|Sweden|Taiwan 1
Brazil|China|Germany|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Chile|Colombia|Czech Republic|Denmark|Finland|France|Greece|Hong Kong|Hungary|India|Israel|Korea, Republic of|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Peru|Philippines|Poland|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom|Venezuela 1
Bulgaria 1
Bulgaria|France|Germany|Poland|Russian Federation|Turkey|Ukraine 1
Canada|Chile|Czechia|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Denmark|France|Germany|Korea, Republic of|Malaysia|Mexico|Netherlands|Poland|Romania|Russian Federation|South Africa|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Canada|Czechia|Germany|Italy|Netherlands|United Kingdom 1
Canada|Germany 1
Canada|Germany|United Kingdom 1
Canada|Italy|Norway|Spain 1
China|Korea, Republic of|Singapore|Taiwan 1
Colombia|Czech Republic|Denmark|France|Germany|Mexico|Spain 1
Croatia 1
Croatia|Netherlands|New Zealand 1
Cyprus|Greece|Israel 1
Czech Republic|Denmark|Hungary|Netherlands|Norway|Poland|Slovakia|Sweden 1
Czech Republic|France|Italy|Netherlands|Serbia|Slovakia|United Kingdom 1
Czech Republic|Germany|Spain 1
Czechia|France|Germany|Hungary|Italy|Netherlands|Spain|Switzerland 1
Czechia|Germany 1
Czechia|Germany|Netherlands|Poland|United Kingdom 1
Czechia|Hungary|Italy|Poland|Spain 1
Czechia|Italy|United Kingdom 1
Czechia|Japan 1
Denmark|Finland|Germany|Hungary|Netherlands|Norway|Poland|Sweden 1
Denmark|Finland|Norway|Sweden 1
Denmark|Germany|Netherlands|Switzerland 1
Denmark|Netherlands 1
Denmark|Norway|Poland|Russian Federation|Slovakia|Sweden 1
Denmark|Norway|Poland|Russian Federation|Sweden|United Kingdom 1
Denmark|Norway|Sweden 1
Denmark|Russian Federation|Sweden 1
Denmark|Spain 1
Denmark|United States|Belgium|Brazil|Canada|China|Finland|France|Germany|Greece|Italy|Netherlands|Portugal|Singapore|South Africa|Spain|United Kingdom 1
Denmark|United States|Canada|Sweden 1
France|Australia|Austria|Bulgaria|Czech Republic|Estonia|Germany|Hungary|India|Israel|Japan|Korea, Republic of|Malaysia|Netherlands|Philippines|Poland|Russian Federation|Slovakia|South Africa|Spain|Thailand|Ukraine|United Kingdom 1
France|Germany|Greece 1
France|Germany|Spain|United Kingdom 1
France|Japan|Netherlands 1
France|United States|Belgium|Canada|Germany|Italy|Japan|Netherlands|Russian Federation|Spain|United Kingdom 1
Germany|Greece|Netherlands|Poland|Serbia|Switzerland|United Kingdom 1
Germany|Hungary|Spain 1
Germany|Italy|Spain|United Kingdom 1
Germany|Italy|Sweden 1
Germany|Spain|United Kingdom 1
Germany|Switzerland 1
Germany|United Kingdom 1
Germany|United States|Belgium|France|United Kingdom 1
Greece|Netherlands 1
Greece|Russian Federation 1
Hungary|Netherlands 1
Hungary|Ukraine|Bulgaria|Czechia 1
India 1
India|Israel|Italy|Poland|Portugal|Thailand|Turkey|Ukraine|France|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czechia|Denmark|Estonia|Finland|Germany|Greece|Guatemala|Hungary|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Peru|Philippines|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
Ireland 1
Italy|Switzerland 1
Italy|United Kingdom 1
Italy|United States|Austria|Belgium|Bulgaria|Czechia|Denmark|France|Germany|Hungary|Israel|Netherlands|Poland|Romania|Russian Federation|Spain|Sweden|Ukraine|United Kingdom 1
Italy|United States|Austria|Belgium|Canada|France|Germany|Japan|Korea, Republic of|Netherlands|Poland|Spain|Switzerland|United Kingdom 1
Mexico 1
Netherlands|Switzerland|United Kingdom 1
Netherlands|United Kingdom 1
New Zealand|Singapore|Australia|Hong Kong|Japan|Korea, Republic of|Malaysia|South Africa|Taiwan|Thailand 1
Nigeria 1
Romania 1
Singapore 1
South Africa 1
Sweden|United Kingdom 1
Tunisia 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Czechia|Denmark|Finland|France|Germany|Greece|Hong Kong|India|Indonesia|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Norway|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Czechia|Denmark|Finland|France|Germany|Hong Kong|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Canada|Chile|China|Czech Republic|Estonia|Finland|France|Germany|Italy|Korea, Republic of|Mexico|Morocco|Netherlands|Poland|Russian Federation|Sweden|Tunisia|Turkey 1
United States|Argentina|Australia|Austria|Belgium|Canada|Chile|China|Czech Republic|Finland|Germany|Greece|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Morocco|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|Thailand|Tunisia|Turkey|United Kingdom 1
United States|Argentina|Australia|Canada|Chile|Denmark|France|Germany|Hungary|Italy|Japan|Netherlands|Poland|Russian Federation|Spain|Sweden|Switzerland 1
United States|Argentina|Australia|Canada|South Africa 1
United States|Argentina|Belgium|Brazil|Canada|Denmark|Estonia|France|Germany|Greece|Hungary|India|Italy|Korea, Republic of|Latvia|Mexico|Netherlands|New Zealand|Norway|Romania|Spain|Sweden|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Canada|Chile|Denmark|Mexico|Sweden 1
United States|Argentina|Canada|Denmark|India|Poland 1
United States|Argentina|Canada|Denmark|South Africa|Sweden 1
United States|Argentina|Czech Republic|Former Serbia and Montenegro|Germany|Israel|Poland|Romania|Russian Federation|Slovakia|South Africa|Ukraine|United Kingdom 1
United States|Australia 1
United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Netherlands|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Australia|Belgium|France|Germany|Netherlands|Spain 1
United States|Australia|Brazil|Canada|India|Israel|Latvia|Lithuania|Poland|Russian Federation|South Africa|Ukraine|United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|China|Czechia|Germany|Italy|Korea, Republic of|Russian Federation|United Kingdom 1
United States|Australia|Canada|Denmark|France|Italy|Netherlands|New Zealand|Poland|United Kingdom 1
United States|Australia|Canada|Netherlands 1
United States|Australia|Czechia|France|Germany|Portugal|Spain|Sweden|United Kingdom 1
United States|Australia|Germany|Italy 1
United States|Austria|Belgium|Denmark|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Austria|Canada|Germany|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|Austria|Denmark|Germany|Greece|Italy|Japan|Netherlands|Norway|Spain|Switzerland|United Kingdom 1
United States|Austria|Germany|Italy|Netherlands|Slovenia|Spain 1
United States|Belarus|Belgium|Bosnia and Herzegovina|Canada|Chile|Latvia|Mexico|Moldova, Republic of|Russian Federation|Slovakia|Ukraine 1
United States|Belgium|Canada|Czechia|Denmark|Germany|Hungary|Italy|Netherlands|Norway|Spain|Switzerland|United Kingdom 1
United States|Belgium|Canada|Denmark|Germany|Israel|Italy|Japan|Korea, Republic of|Romania|Spain|Sweden 1
United States|Belgium|Germany 1
United States|Belgium|Germany|Netherlands 1
United States|Brazil|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|China|Colombia|Czechia|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Brazil|Canada|Czechia|Italy 1
United States|Bulgaria|Germany|Hungary|Italy|Poland 1
United States|Canada|China|Spain 1
United States|Canada|Czech Republic|France|Germany|Hungary|Italy|Netherlands|Portugal 1
United States|Canada|Czechia|France|Italy 1
United States|Canada|Czechia|Germany|Italy 1
United States|Canada|Denmark|Netherlands 1
United States|Canada|Germany 1
United States|Canada|Hungary|Netherlands|Poland|Serbia 1
United States|Canada|Japan 1
United States|Colombia 1
United States|Colombia|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|France|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Norway|Peru|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Slovakia|Spain|Sweden|Switzerland|Ukraine|United Kingdom|Virgin Islands (U.S.) 1
United States|Czech Republic|Germany 1
United States|Czech Republic|Poland|Russian Federation|Ukraine 1
United States|Czechia|France|Italy 1
United States|Czechia|Germany 1
United States|Czechia|Russian Federation 1
United States|Denmark|Sweden 1
United States|France|Switzerland 1
United States|Germany|Israel|Italy|Netherlands|Poland|United Kingdom 1
United States|Germany|Netherlands 1
United States|Greece|Russian Federation 1
United States|Hungary|Italy|Saudi Arabia|Slovakia|South Africa|United Kingdom 1
United States|Israel 1
United States|Japan 1
United States|Puerto Rico 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 626
2 77
3 41
4 29
5 14
6 16
7 16
8 10
9 9
10 14
11 8
12 13
13 5
14 3
15 11
16 6
17 6
18 9
19 7
20 6
21 5
22 5
23 7
24 5
25 4
26 5
27 1
28 5
29 2
30 5
31 3
32 2
33 1
34 2
35 1
36 2
37 2
38 5
39 2
40 4
41 1
44 3
49 2
51 1
53 1
54 2
57 2
58 2
60 1
62 1
64 1
67 2
75 1
81 1
82 1
84 1
87 1
91 1
97 1
100 1
101 1
103 2
111 1
113 1
114 1
116 1
118 1
127 1
129 1
130 1
132 1
152 1
165 2
170 1
178 2
200 1
223 1
230 2
233 1
356 1
421 1
503 1
567 1
626 1
959 1
984 1
1016 1
1113 1

Phase

Phase Study_Count
N/A 609
Phase 4 173
Phase 3 145
Phase 2 86
Phase 1 17
Phase 2/Phase 3 12
Phase 1/Phase 2 7
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 212
2 651
3 74
4 40
5 5
6 4
7 1
8 1
9 1
10 1
11 1
NA 62

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0 1.000 13.00000 13.0 3.0000 48.0000 5.000 10.0000
1st Qu. 17.5 60.000 20.00000 23.0 50.0000 60.0000 120.000 80.0000
Median 30.0 122.000 40.00000 50.0 130.0000 205.0000 253.500 176.0000
Mean 30.0 4307.916 60.94118 62.0 220.7882 280.8333 1368.907 768.4566
3rd Qu. 42.5 300.000 58.00000 97.5 234.0000 431.0000 659.250 398.0000
Max. 50.0 1260576.000 280.00000 130.0 1280.0000 800.0000 21105.000 52000.0000

Trial Group Type

group_type Group_Count
Experimental 874
Active Comparator 709
Other 147
No Intervention 145
Placebo Comparator 108
NA 62
Sham Comparator 7

Intervention Model

intervention_model Study_Count
Parallel Assignment 752
Single Group Assignment 250
Crossover Assignment 30
Factorial Assignment 11
Sequential Assignment 5
NA 5

Primary Purpose

primary_purpose Study_Count
Treatment 636
Prevention 199
Diagnostic 83
Other 37
Supportive Care 22
Health Services Research 21
Screening 21
NA 14
Basic Science 12
Device Feasibility 7
Educational/Counseling/Training 1

Observational Studies

Studies by Country

Country Study_Count
United States 113
NA 50
France 35
Germany 35
Spain 22
United Kingdom 22
China 17
Korea, Republic of 17
Canada 16
Sweden 15
Finland 13
Italy 11
Japan 11
Switzerland 10
Denmark 8
Netherlands 8
Greece 6
Norway 6
Belgium 5
Russian Federation 5
Taiwan 5
Turkey 5
Poland 4
Austria 3
Germany|Netherlands 3
Germany|Switzerland 3
Israel 3
Thailand 3
Argentina 2
Korea, Republic of|Taiwan 2
United States|Puerto Rico 2
Argentina|Azerbaijan|Bahrain|Chile|Colombia|Egypt|Georgia|Jordan|Kazakhstan|Kenya|Lebanon|Mexico|Russian Federation|Saudi Arabia|United Arab Emirates|Uruguay|Venezuela 1
Argentina|Canada|Chile|Germany|Italy|Spain 1
Australia 1
Australia|Austria|France|Italy|Portugal|South Africa 1
Australia|Belgium|Canada|France|Germany|Italy|Monaco|United Kingdom 1
Australia|China|Hong Kong|Korea, Republic of|Malaysia|Philippines|Taiwan|Thailand 1
Austria|Belarus|Czech Republic|Finland|Germany|Italy|Netherlands|Portugal|Russian Federation|Slovakia|Slovenia|Spain|Sweden|Switzerland|United Arab Emirates|United Kingdom 1
Austria|Belgium|Bulgaria|Croatia|Czechia|Denmark|Estonia|France|Germany|Greece|Ireland|Italy|Latvia|Netherlands|Norway|Poland|Portugal|Romania|Slovenia|Spain|Sweden|United Kingdom 1
Austria|Bulgaria|Czechia|Estonia|Hungary|Israel|Latvia|Poland|Romania|Russian Federation|Serbia|Slovenia 1
Austria|Denmark|Finland|Germany|Spain|Sweden 1
Belgium|Denmark|Greece|Netherlands|Norway|Portugal|Sweden 1
Belgium|Ireland|Italy|Netherlands|Portugal|Spain 1
Bulgaria|Czech Republic|Denmark|France|Germany|Slovakia|Spain|United Kingdom 1
Bulgaria|France|Germany|Poland|Russian Federation|Turkey|Ukraine 1
Canada|Netherlands 1
Canada|Sweden 1
Colombia 1
Czech Republic|United Kingdom 1
Czechia 1
Czechia|France|Germany|Netherlands|Spain|Switzerland 1
Denmark|France|Germany|Ireland|Italy|Netherlands|Poland|Spain|United Kingdom 1
Denmark|Germany|Hong Kong|Ireland|Italy|Poland|Spain|Sweden|Thailand 1
Egypt 1
France|Italy|Switzerland 1
Germany|China|Croatia|Egypt|Lebanon|Netherlands|Spain|Turkey 1
Germany|France|Hungary 1
Hong Kong 1
Hong Kong|India|Indonesia|Korea, Republic of|Malaysia|Pakistan|Philippines|Singapore|Taiwan|Thailand|Vietnam 1
Hong Kong|India|Korea, Republic of|Singapore|Taiwan|Thailand 1
India 1
Indonesia|Korea, Republic of|Malaysia|Singapore|Thailand 1
Ireland 1
Jordan 1
Lithuania 1
Puerto Rico 1
Romania 1
Slovakia 1
Slovenia|Sweden|Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Hungary|Ireland|Israel|Moldova, Republic of|Netherlands|Norway|Poland|Portugal|Russian Federation|Slovakia|Ukraine|United Kingdom 1
Tunisia 1
United States|Argentina|Brazil|Canada|Chile|China|Colombia|Ecuador|Hong Kong|Japan|Korea, Republic of|Lebanon|Mexico|Peru|Russian Federation|Saudi Arabia|Singapore|South Africa|Taiwan|United Arab Emirates|Venezuela 1
United States|Australia|Belgium|France|Germany|Netherlands|Spain 1
United States|Australia|Canada 1
United States|Australia|France 1
United States|Belgium|Canada|Greece|Netherlands 1
United States|Canada 1
United States|Germany|Israel|United Kingdom 1
United States|Greece 1
United States|Monaco 1
United States|Netherlands 1
United States|New Zealand 1
United States|Puerto Rico|Virgin Islands (U.S.) 1
Venezuela 1

Sites per Study

Site_count Study_Count
1 378
2 33
3 15
4 11
5 5
6 6
7 4
8 6
9 6
10 1
11 1
12 1
13 4
15 1
16 1
17 2
18 1
19 2
21 3
22 3
23 1
24 2
26 1
27 1
28 1
29 1
32 1
39 1
40 1
42 1
45 1
47 1
50 1
55 1
56 1
62 1
75 1
100 1
140 1
148 1
161 1
171 1
220 1
523 1
666 1
1164 1
1616 1

Enrollment Metrics

Measure Observational
Min 5.00
1st Qu 100.00
Median 364.00
Mean 13398.68
3rd Qu 1766.00
Max 814446.00

Observation Model

observational_model Study_Count
Cohort 347
Case-Only 62
Case-Control 31
Other 27
Case Control 19
NA 19
Case-Crossover 3
Ecologic or Community 3
Defined Population, Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 338
Retrospective 128
Cross-Sectional 30
Other 9
NA 6
Longitudinal, Retrospective 1

Registries

Studies by Country

Country Study_Count
United States 18
NA 11
Italy 9
Germany 8
Korea, Republic of 6
Canada 5
China 4
France 4
Egypt 3
Poland 3
Russian Federation 3
Spain 3
Finland 2
Netherlands 2
Singapore 2
Sweden 2
Switzerland 2
Australia|Belgium|Chile|Denmark|Finland|France|Germany|Ireland|Israel|Italy|Netherlands|Norway|Poland|Spain|Sweden|United Kingdom 1
Australia|Hong Kong|Indonesia|Korea, Republic of|Malaysia|Saudi Arabia|Thailand 1
Austria 1
Austria|Belgium|France|Germany|Switzerland 1
Austria|Denmark|Sweden 1
Austria|Germany 1
Belgium 1
Belgium|Austria|Canada|China|Czechia|France|Germany|India|Italy|Korea, Republic of|Netherlands|Portugal|Saudi Arabia|Spain|United Kingdom 1
Belgium|France|Germany|Ireland|Italy|Netherlands|Poland|Portugal|Russian Federation|Saudi Arabia|Spain|United Arab Emirates|United Kingdom 1
Belgium|Netherlands 1
Brazil 1
China|Hong Kong|Japan|Korea, Republic of|Taiwan 1
Colombia 1
Czechia|Germany|Ireland|Spain|United Kingdom 1
Denmark 1
France|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Poland|Portugal|Spain|Switzerland|United Kingdom 1
France|United Kingdom 1
Greece 1
Indonesia 1
Israel 1
Japan 1
Latvia 1
Mexico|United States|Argentina|Austria|Belgium|Brunei Darussalam|Chile|China|Colombia|Czechia|Germany|Greece|Hungary|Iceland|Indonesia|Italy|Japan|Kazakhstan|Korea, Republic of|Kuwait|Malaysia|Oman|Philippines|Poland|Portugal|Russian Federation|Saudi Arabia|Serbia|Singapore|Slovakia|South Africa|Spain|Switzerland|Taiwan|Thailand|United Arab Emirates|United Kingdom 1
Netherlands|Russian Federation 1
Tunisia 1
Turkey 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 80
2 7
3 2
4 3
9 4
12 1
13 1
15 1
16 1
20 1
21 2
25 1
41 1
47 1
51 1
62 2
90 1
91 1
98 1
125 1
154 1

Enrollment Metrics

Measure Registries
Min 1.0
1st Qu 250.0
Median 905.0
Mean 119954.8
3rd Qu 2163.5
Max 7205000.0

Registry Model

observational_model Study_Count
Cohort 83
Case-Only 16
Case-Control 6
Other 5
Ecologic or Community 2
Case-Crossover 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 104
Other 5
Cross-Sectional 3
Retrospective 1
NA 1

Follow-up

target_duration Study_Count
12 Months 21
1 Year 16
2 Years 14
5 Years 11
1 Day 8
3 Years 8
10 Years 5
24 Months 5
1 Month 4
18 Months 2
3 Months 2
30 Days 2
6 Months 2
105 Months 1
12 Weeks 1
15 Years 1
17 Years 1
2 Days 1
3 Days 1
36 Months 1
4 Months 1
4 Weeks 1
4 Years 1
60 Days 1
60 Months 1
8 Weeks 1
90 Days 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03389074 Evaluation of Optimal Ablation Index for Pulmonary Vein Isolation in Patients With AF Prospective Registry https://ClinicalTrials.gov/show/NCT03389074 Active, not recruiting Seoul National University Hospital 2019-09-09
NCT03362788 The Greek AntiPlatElet Atrial Fibrillation Registry. https://ClinicalTrials.gov/show/NCT03362788 Recruiting Attikon Hospital 2020-06-30
NCT03303872 Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) https://ClinicalTrials.gov/show/NCT03303872 Recruiting Yonsei University 2019-12-31
NCT03279406 REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion https://ClinicalTrials.gov/show/NCT03279406 Completed University Hospital, Tours 2018-06-01
NCT03277976 Pulmonary Vein Isolation Guided by Ablation Index (Ablation Index Registry Study) https://ClinicalTrials.gov/show/NCT03277976 Active, not recruiting Clinica Mediterranea 2018-09-28
NCT03272620 Atrial Fibrillation at the Viennese University Emergency Department https://ClinicalTrials.gov/show/NCT03272620 Recruiting Medical University of Vienna 2020-01-01
NCT03223207 CareLink Express (CLE Research) https://ClinicalTrials.gov/show/NCT03223207 Completed Baylor Research Institute 2018-08-27
NCT03188484 Atrial Fibrillation Research In CATalonia https://ClinicalTrials.gov/show/NCT03188484 Recruiting Jordi Gol i Gurina Foundation 2017-04-30
NCT03091452 CArdioSurgEry Atrial Fibrillation Register https://ClinicalTrials.gov/show/NCT03091452 Recruiting Stiftung Institut fuer Herzinfarktforschung 2019-12-31
NCT03085576 NATional TUnisian REgistry of Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03085576 Completed Dacima Consulting 2018-05-30
NCT03075930 Atrial Fibrillation Ablation Registry https://ClinicalTrials.gov/show/NCT03075930 Recruiting Maastricht University Medical Center 2022-01-31
NCT03051061 Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03051061 Recruiting Henan Institute of Cardiovascular Epidemiology 2019-12-01
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) https://ClinicalTrials.gov/show/NCT03041233 Active, not recruiting Abbott Medical Devices 2020-04-27
NCT03040037 Cryoballoon Atrial Fibrillation Ablation Registry https://ClinicalTrials.gov/show/NCT03040037 Recruiting Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 2020-07-01
NCT03014557 China REgistry of WATCHMAN https://ClinicalTrials.gov/show/NCT03014557 Recruiting Fu Wai Hospital, Beijing, China 2023-12-31
NCT03004859 Opportunistic Screening in Pharmacies for Atrial Fibrillation in Seniors (>65 Years) https://ClinicalTrials.gov/show/NCT03004859 Completed RWTH Aachen University 2018-08-22
NCT02978248 ARENA - Project Atrial Fibrilation Rhine-Neckar Region https://ClinicalTrials.gov/show/NCT02978248 Recruiting Stiftung Institut fuer Herzinfarktforschung 2018-12-31
NCT02950168 Edoxaban Management in Diagnostic and Therapeutic Procedures https://ClinicalTrials.gov/show/NCT02950168 Completed Daiichi Sankyo, Inc. 2018-07-26
NCT02893215 Silent Atrial Fibrillation - Screening of High-risk Groups for Atrial Fibrillation (The Silence Study) https://ClinicalTrials.gov/show/NCT02893215 Recruiting Hvidovre University Hospital 2018-09-30
NCT02830750 Low Fluoroscopy Afib Ablation Registry https://ClinicalTrials.gov/show/NCT02830750 Completed Stanford University 2018-04-30
NCT02790801 The First Russian Observational Survey of Heart Failure Patients With Atrial Fibrillation https://ClinicalTrials.gov/show/NCT02790801 Completed Federal State Budgetary Scientific Institution, Research Institute of Cardiology 2017-05-31
NCT02752737 Cryo AF Global Registry https://ClinicalTrials.gov/show/NCT02752737 Active, not recruiting Medtronic Cardiac Rhythm and Heart Failure 2022-12-31
NCT02743416 Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II https://ClinicalTrials.gov/show/NCT02743416 Active, not recruiting Karolinska University Hospital 2023-04-30
NCT02741349 Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation https://ClinicalTrials.gov/show/NCT02741349 Recruiting Saint Antoine University Hospital 2021-12-31
NCT02663076 Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry https://ClinicalTrials.gov/show/NCT02663076 Recruiting GWT-TUD GmbH 2020-12-31
NCT02635230 What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. https://ClinicalTrials.gov/show/NCT02635230 Recruiting R&D Cardiologie 2021-01-31
NCT02587624 Remote MAGNetic Catheter Ablation for Atrial Fibrillation https://ClinicalTrials.gov/show/NCT02587624 Recruiting Paracelsus Medical University 2017-12-31
NCT02699957 Left Atrial Appendage Occlusion Registry (LAAO Registry) https://ClinicalTrials.gov/show/NCT02699957 Recruiting American College of Cardiology 2026-01-31
NCT02565238 BIO.MASTER.BioMonitor 2 Study https://ClinicalTrials.gov/show/NCT02565238 Completed Biotronik SE & Co. KG 2016-10-31
NCT02563639 Apixaban in Atrial Fibrillation Registry https://ClinicalTrials.gov/show/NCT02563639 Completed IHF GmbH - Institut für Herzinfarktforschung 2018-08-31
NCT02533752 Canadian WATCHMAN Registry https://ClinicalTrials.gov/show/NCT02533752 Recruiting Cardiology Research UBC 2020-09-30
NCT02518984 Atrial Fibrillation General Registry https://ClinicalTrials.gov/show/NCT02518984 Completed European Society of Cardiology 2019-08-31
NCT02516033 Hybrid Atrial Fibrillation Ablation Registry https://ClinicalTrials.gov/show/NCT02516033 Enrolling by invitation University Medical Center Groningen 2021-01-31
NCT02507856 Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA https://ClinicalTrials.gov/show/NCT02507856 Recruiting University Hospital, Essen 2021-06-30
NCT02485288 PaTH Clinical Data Research Network (CDRN) Atrial Fibrillation (AF) Clinician-Patient Partnership Cohort https://ClinicalTrials.gov/show/NCT02485288 Active, not recruiting University of Pittsburgh 2020-09-30
NCT02461602 Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients https://ClinicalTrials.gov/show/NCT02461602 Completed Duke University 2018-05-31
NCT02447081 Amplatzerâ„¢Amuletâ„¢ Post-Market Study (Amuletâ„¢PMS) https://ClinicalTrials.gov/show/NCT02447081 Completed Abbott Medical Devices 2018-10-23
NCT02433613 Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry) https://ClinicalTrials.gov/show/NCT02433613 Completed Medtronic Cardiac Rhythm and Heart Failure 2018-11-20
NCT02366338 PRescriptiOn PattERns Of Oral Anticoagulants https://ClinicalTrials.gov/show/NCT02366338 Completed Muğla Sıtkı Koçman University 2014-11-30
NCT02349269 Postoperative Atrial Fibrillation and Long-term Survival https://ClinicalTrials.gov/show/NCT02349269 Completed Kuopio University Hospital 2012-12-31
NCT02344173 ABLATOR Ablation Observational Registry https://ClinicalTrials.gov/show/NCT02344173 Completed Abbott Medical Devices 2017-08-18
NCT02344901 ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES) https://ClinicalTrials.gov/show/NCT02344901 Completed Muğla Sıtkı Koçman University 2015-04-30
NCT02334852 Registry of Atrial Fibrillation and Embolic Risk in Mexico https://ClinicalTrials.gov/show/NCT02334852 Completed Registro de Fibrilación Auricular y Riesgo Embólico en México 2016-12-31
NCT02306460 Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation https://ClinicalTrials.gov/show/NCT02306460 Recruiting Tampere University Hospital 2020-12-31
NCT02306824 Berlin Atrial Fibrillation Registry https://ClinicalTrials.gov/show/NCT02306824 Active, not recruiting Charite University, Berlin, Germany 2017-11-30
NCT02252861 French Database of Left Atrial Appendage Closure https://ClinicalTrials.gov/show/NCT02252861 Active, not recruiting Henri Mondor University Hospital 2019-09-30
NCT02219984 START-Register: Survey on Anticoagulated Patients Register https://ClinicalTrials.gov/show/NCT02219984 Recruiting St. Orsola Hospital 2023-07-31
NCT02155907 Atrial Fibrillation Detected by ELR and Holter Recording, a Comparison in Patients With Ischemic Stroke or TIA https://ClinicalTrials.gov/show/NCT02155907 Completed University of Aarhus 2017-12-31
NCT02145858 Prevention of Retained-Blood Outcomes With Active Clearance Technology https://ClinicalTrials.gov/show/NCT02145858 Completed ClearFlow, Inc. 2016-07-31
NCT02032030 Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys https://ClinicalTrials.gov/show/NCT02032030 Active, not recruiting Washington University School of Medicine 2020-07-31
NCT02018497 Essential Hypotension and Allostasis Registry https://ClinicalTrials.gov/show/NCT02018497 Recruiting CES University 2020-07-30
NCT01972295 Registry on WATCHMAN Outcomes in Real-Life Utilization WASP Registry https://ClinicalTrials.gov/show/NCT01972295 Completed Boston Scientific Corporation 2018-01-23
NCT01972282 Registry on WATCHMAN Outcomes in Real-Life Utilization https://ClinicalTrials.gov/show/NCT01972282 Completed Boston Scientific Corporation 2015-11-30
NCT01867099 Ten-year Outcomes After AF Ablation https://ClinicalTrials.gov/show/NCT01867099 Completed Valley Health System 2012-12-31
NCT01871194 An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®). https://ClinicalTrials.gov/show/NCT01871194 Completed Drug Safety Research Unit, Southampton, UK 2016-01-31
NCT01816308 Cognitive Impairment in Atrial Fibrillation https://ClinicalTrials.gov/show/NCT01816308 Recruiting Texas Cardiac Arrhythmia Research Foundation 2020-06-30
NCT01796093 Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function https://ClinicalTrials.gov/show/NCT01796093 Completed Cocco, Giuseppe, M.D. 2012-02-29
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol https://ClinicalTrials.gov/show/NCT01786486 Completed Abbott Medical Devices 2013-12-31
NCT01774357 Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems https://ClinicalTrials.gov/show/NCT01774357 Completed Biotronik SE & Co. KG 2018-09-30
NCT01759225 Registry of Cardiovascular Disease Patients https://ClinicalTrials.gov/show/NCT01759225 Enrolling by invitation Maccabi Healthcare Services, Israel 2100-12-31
NCT02024230 Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation https://ClinicalTrials.gov/show/NCT02024230 Recruiting Fujita Health University 2018-12-31
NCT04435418 Eliquis Acute Stroke Safety Evaluation https://ClinicalTrials.gov/show/NCT04435418 Completed University of Alberta 2019-09-09
NCT04419012 Polish Atrial Fibrillation (POL-AF) Registry https://ClinicalTrials.gov/show/NCT04419012 Active, not recruiting Jan Kochanowski University 2020-06-30
NCT04375241 Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older https://ClinicalTrials.gov/show/NCT04375241 Recruiting Diagram B.V. 2021-03-01
NCT04347187 REGistry of Long-term AnTithrombotic TherApy-2 https://ClinicalTrials.gov/show/NCT04347187 Recruiting National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 2025-12-31
NCT04322474 Russian National Registry of LAAO https://ClinicalTrials.gov/show/NCT04322474 Completed National Research Center for Preventive Medicine 2017-12-30
NCT04315974 Italian Registry In the Setting of AF Ablation With Rivaroxaban (IRIS) https://ClinicalTrials.gov/show/NCT04315974 Recruiting Azienda Policlinico Umberto I 2022-03-31
NCT04307225 Atrial Fibrillation After CABG and PCI https://ClinicalTrials.gov/show/NCT04307225 Recruiting Region Örebro County 2020-12-31
NCT04222868 Indonesian Registry on Atrial Fibrillation https://ClinicalTrials.gov/show/NCT04222868 Recruiting Indonesian Heart Rhythm Society 2020-12-30
NCT04195113 Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry https://ClinicalTrials.gov/show/NCT04195113 Recruiting McMaster University 2022-08-31
NCT04193813 Predictors of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Prospective Cohort Study https://ClinicalTrials.gov/show/NCT04193813 Completed Ain Shams University 2019-03-18
NCT04125641 Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation https://ClinicalTrials.gov/show/NCT04125641 Recruiting Yonsei University 2022-08-31
NCT04097132 Pattern of Non Valvular Atrial Fibrillation in Acute Ischemic Stroke Patients at Assiut University Hospitals https://ClinicalTrials.gov/show/NCT04097132 Recruiting Assiut University 2021-01-01
NCT04088071 Registry for Real-world Experience of Catheter Ablation for Symptomatic Paroxysmal Atrial Fibrillation https://ClinicalTrials.gov/show/NCT04088071 Enrolling by invitation Heart Rhythm Clinical and Research Solutions, LLC 2022-06-30
NCT04085731 Driver-guided Ablation of Persistent Atrial Fibrillatiom https://ClinicalTrials.gov/show/NCT04085731 Recruiting IRCCS Policlinico S. Donato 2021-09-21
NCT04055961 Atrial Fibrillation Ablation Registry https://ClinicalTrials.gov/show/NCT04055961 Recruiting Hoag Memorial Hospital Presbyterian 2025-05-20
NCT04080830 Registration Study of Acute Ischemic Stroke/Transient Ischemic Attack (TIA) With Atrial Fibrillation https://ClinicalTrials.gov/show/NCT04080830 Recruiting Xuanwu Hospital, Beijing 2021-12-30
NCT04042155 Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD) https://ClinicalTrials.gov/show/NCT04042155 Recruiting Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2022-08-01
NCT04024124 A Ring-type Wearable Device for Atrial Fibrillation Among Ambulatory Patients https://ClinicalTrials.gov/show/NCT04024124 Recruiting Seoul National University Hospital 2023-08-31
NCT04010955 Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON) https://ClinicalTrials.gov/show/NCT04010955 Recruiting Asan Medical Center 2023-08-31
NCT04023188 A Ring-type Wearable Device for Atrial Fibrillation https://ClinicalTrials.gov/show/NCT04023188 Active, not recruiting Seoul National University Hospital 2020-08-30
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific https://ClinicalTrials.gov/show/NCT04022954 Recruiting Abbott Medical Devices 2020-08-31
NCT04005508 OSA and CV Outcomes in Patients With High Risk AF https://ClinicalTrials.gov/show/NCT04005508 Recruiting National University, Singapore 2023-06-30
NCT03963349 THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study https://ClinicalTrials.gov/show/NCT03963349 Recruiting Biosense Webster, Inc. 2022-01-31
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions https://ClinicalTrials.gov/show/NCT03847753 Completed University of Aarhus 2016-12-31
NCT03838341 Stand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation. https://ClinicalTrials.gov/show/NCT03838341 Recruiting Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 2020-12-31
NCT03836339 Assessment of Atrial Fibrillation in Emergency Department https://ClinicalTrials.gov/show/NCT03836339 Active, not recruiting RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la vallée du Rhône 2019-12-31
NCT03818724 Treatment Success With the CoolLoop Cryoablation System https://ClinicalTrials.gov/show/NCT03818724 Recruiting AFreeze GmbH 2025-01-31
NCT03760705 Singapore Cardiac Longitudinal Outcomes Database https://ClinicalTrials.gov/show/NCT03760705 Active, not recruiting National Heart Centre Singapore 2025-12-31
NCT03737838 Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF) https://ClinicalTrials.gov/show/NCT03737838 Recruiting University of Chicago 2020-11-30
NCT03695484 Registry Evaluating AF Ablation Techniques https://ClinicalTrials.gov/show/NCT03695484 Recruiting Erasmus Medical Center 2021-10-31
NCT03653598 BLITZ Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03653598 Completed Heart Care Foundation 2016-12-30
NCT03656523 Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI https://ClinicalTrials.gov/show/NCT03656523 Active, not recruiting Heart Care Foundation 2020-01-30
NCT02270112 Enhanced Diagnostics for Early Detection of Atrial Fibrillation https://ClinicalTrials.gov/show/NCT02270112 Completed University Hospital, Basel, Switzerland 2015-10-31
NCT03627806 FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF) https://ClinicalTrials.gov/show/NCT03627806 Recruiting University of Miami 2021-01-31
NCT03620656 The Validation of the FibriCheck Application for the Detection of Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03620656 Completed Qompium NV 2019-07-01
NCT03591627 Left Atrial Thrombus on Transesophageal Echocardiography https://ClinicalTrials.gov/show/NCT03591627 Recruiting Medical University of Warsaw 2019-09-30
NCT03589170 ATRIAL FIBRILATION OPPORTUNISTIC SCREENING AND STROKE (AFOSS). https://ClinicalTrials.gov/show/NCT03589170 Active, not recruiting Jordi Gol i Gurina Foundation 2017-12-31
NCT03546439 VAscular Closure for Cardiac Ablation Registry (VACCAR) https://ClinicalTrials.gov/show/NCT03546439 Recruiting Saint Luke’s Health System 2020-10-31
NCT03524924 Edoxaban and Frailty in Senior Individuals https://ClinicalTrials.gov/show/NCT03524924 Completed University of Padova 2020-02-01
NCT03505801 Confirm Rx SMART Registry https://ClinicalTrials.gov/show/NCT03505801 Recruiting Abbott Medical Devices 2020-01-31
NCT03491202 The Genetic Basis for Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03491202 Recruiting Jesse Brown VA Medical Center 2022-05-31
NCT03488420 Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE https://ClinicalTrials.gov/show/NCT03488420 Recruiting Montreal Heart Institute 2021-03-01
NCT03446794 Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis https://ClinicalTrials.gov/show/NCT03446794 Recruiting Fundación EPIC 2021-03-01
NCT03444259 Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients https://ClinicalTrials.gov/show/NCT03444259 Recruiting University of Turku 2025-12-31
NCT03436082 Post-Market Surveillance With a Novel mHealth Platform https://ClinicalTrials.gov/show/NCT03436082 Completed Yale University 2018-12-25
NCT03428048 Cardiovascular Innovation & Research Institute ’s NEXUS Registry, the Whole is Greater Than the Parts. https://ClinicalTrials.gov/show/NCT03428048 Recruiting Cardiovascular Innovation and Research Institute 2026-03-31
NCT03487419 Echocardiographic Left Atrial Function Assessment and Atrial Fibrillation Post-Coronary Artery Bypass Surgery https://ClinicalTrials.gov/show/NCT03487419 Recruiting National Heart Institute, Egypt 2019-12-30
NCT02362659 Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry https://ClinicalTrials.gov/show/NCT02362659 Completed Icahn School of Medicine at Mount Sinai 2018-11-15
NCT02401854 Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder https://ClinicalTrials.gov/show/NCT02401854 Completed Population Health Research Institute 2015-03-31
NCT02919982 Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation https://ClinicalTrials.gov/show/NCT02919982 Active, not recruiting Baim Institute for Clinical Research 2018-05-31
NCT02444221 Rivaroxaban Evaluation in Real Life Settings https://ClinicalTrials.gov/show/NCT02444221 Active, not recruiting Thrombosis Research Institute 2019-05-31
NCT04075084 Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs) https://ClinicalTrials.gov/show/NCT04075084 Recruiting Biotronik SE & Co. KG 2021-10-31
NCT03760874 Atrial Fibrillation Research Database https://ClinicalTrials.gov/show/NCT03760874 Recruiting University of Campania “Luigi Vanvitelli” 2022-01-01